Join the club for FREE to access the whole archive and other member benefits.

Matt Kaeberlein

Professor at University of Washington and chair of the American Aging Association

Matt Kaeberlein, Ph.D., is recognized globally for his research on the basic biology of aging. The premise of his research is that understanding the molecular mechanisms of aging will lead to interventions that slow the onset and progression of age-related chronic conditions, such as cancer, diabetes, kidney disease, heart disease, Alzheimer’s and others. Dr. Kaeberlein received his Ph.D. from the Massachusetts Institute of Technology in 2002 and performed his post-doctoral research in the Department of Genome Sciences at the University of Washington. Dr. Kaeberlein was appointed as an Assistant Professor of Pathology in 2006 and was promoted to Associate Professor in 2011.

Dr. Matt Kaeberlein is a Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences at the University of Washington. His research interests are focused on basic mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life. He has published nearly 200 papers in top scientific journals and has been recognized by several prestigious awards, including a Breakthroughs in Gerontology Award, an Alzheimer’s Association Young Investigator Award, an Ellison Medical Foundation New Scholar in Aging Award, a Murdock Trust Award, a Pioneer in Aging Award, and the Vincent Cristofalo Rising Star in Aging Research.

Visit website:




See also: Academia University of Washington (UW) - Public research university in Seattle, Washington

Details last updated 13-Feb-2020

Matt Kaeberlein is also referenced in the following:

Academy for Health and Lifespan Research (AHLR)

World's aging researchers unite to accelerate breakthroughs in longevity

American Aging Association

Non-profit dedicated to biomedical aging studies, geroscience and slowing the aging process

BSRA Annual Scientific Meeting 2023

06-Sep-2023 to 08-Sep-2023

A compelling lineup of speakers from all areas of the biology of ageing

Decoding Aging in Dogs (and Humans!)


Decoding Longevity: Dogs, Humans, and the Shared Journey of Aging with Dr. Matt Kaeberlein by Oxford Society of Ageing and Longevity (FREE)

Dr. Matt Kaeberlein| Rapamycin, mTOR, Sirtuins, NAD+ & Dog Aging Project

Live Longer World podcast #5 with Dr. Matt Kaeberlein as a guest

Longevity Hackers

Feature length documentary about longevity and radical life extension with due to be released in 2023

Metabesity 2021

11-Oct-2021 to 14-Oct-2021

The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan

RAADfest 2020

02-Oct-2020 to 04-Oct-2020

The science of staying alive

Rejuveron Age Better Live Longer Symposium


Symposium about healthy living organized by Rejuveron (FREE)

Matt Kaeberlein Blog Posts

Highlights from Longevity Summit Dublin 2023

Highlights from Longevity Summit Dublin 2023

Key points and slides from the leading longevity conference hosted by Aubrey de Grey

Matt Kaeberlein News

Optispan investigates proactive healthcare to increase healthy lifespan

Longevity Technology - 01-Feb-2024

Company aims to shift medicine's focus from illness treatment to proactive health optimization


New AI tool ENABL Age provides personalised insights into healthy ageing

Live Forever Club - 07-Nov-2023

A stepping stone towards personalized anti-ageing interventions


Uncovering the potential of rapamycin from off-label use reports

Live Forever Club - 01-Jun-2023

Friends and family noticed their improved health and appearance, with no serious side effects

Read more... summarises the proceedings of the Buck Institute's Longevity Summit (LEAF) - 20-Jan-2023

Another reminder of the amount of research, with multiple approaches, about to go into clinical trials


Phase 2 clinical trial of lead drug candidate MYMD-1- a therapy for delaying aging

Business Wire - 26-Jul-2022

Sarcopenia drug trial shows no evidence of toxicity or safety issues


University of Washington launches Rapamycin Study

Live Forever Club - 05-Mar-2022

Have you been taking rapamycin supplements recently? Please consider contributing to this study.


First-ever true clinical trial to slow down ageing in dogs

Longevity Technology - 28-Sep-2021

A rapamycin trial testing healthspan improvements in dogs; results may extrapolate to humans as well


Dr. Matt Kaeberlein argues for more funding for geroscience

The Hill - 16-Jul-2021

Chair of American Aging Association disappointed ARPA-H may only receive half the requested funding


Recharge your mitochondrial batteries to live longer

Longevity Technology - 27-May-2021

Breakthrough in longevity research - cellular energetics may stop or even reverse the ageing process


Dog Aging Project invites participants to study canine health and longevity

University of Washington - 13-Apr-2021

Understanding the impact of genes, lifestyle, and environment on ageing


Stealthy Harvard startup wants to reverse aging

MIT Technology Review - 09-May-2018

Rejuvenate Bio is cofounded by George Church of Harvard Medical School. Will make animals “young...


Life extending drug tested on dogs

Deccan Chronicle - 15-Aug-2016

Anti-rejection drug rapamycin extend the life of mice by more than 25 per cent. If similar effec...


Articles written by Matt Kaeberlein

Dr. Matt Kaeberlein argues for more funding for geroscience

The Hill - 16-Jul-2021

Chair of American Aging Association disappointed ARPA-H may only receive half the requested funding